Do You C Us?
Rare and less common cancers account for nearly half of [...]
ASCO 2021: Gut microbiome boosts nivolumab/ipilimumab activity
Recent evidence suggests that the bacteria in the gut (the [...]
Pegilodecakin for metastatic kidney cancer
Combinations of immunotherapy and vascular endothelial growth factor (VEGF) inhibitors [...]
Cellular signatures of kidney tumours
The origins of seven types of kidney cancer, including several [...]
Blood test that detects 50 types of cancer
A simple blood test that can detect more than 50 [...]
World Kidney Cancer Day 2021
World Kidney Cancer Day 2021 takes place this Thursday 17 June. [...]
ASCO 2021: Pembrolizumab plus axitinib continues to improve survival in kidney cancer
The KEYNOTE-426 study of the immune checkpoint inhibitor, pembrolizumab plus [...]
ASCO 2021: Nivolumab plus ipilimumab for the treatment of kidney cancer brain metastases
Brain metastases resulting from the spread of renal cell carcinoma [...]
ASCO 2021: Baseline characteristics affect survival with nivolumab plus cabozantinib
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
ASCO 2021: Nivolumab plus cabozanitinib for non-clear cell kidney cancer
The cabozantinib/nivolumab combination has been shown to be effective at [...]
